These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35060329)

  • 1. Plasmablastic lymphoma with aberrant expression of CD3 and CD4.
    Yan J; Sakhdari A
    Int J Lab Hematol; 2022 Aug; 44(4):692-693. PubMed ID: 35060329
    [No Abstract]   [Full Text] [Related]  

  • 2. CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall.
    Pan Z; Chen M; Zhang Q; Wang E; Yin L; Xu Y; Huang Q; Yuan Y; Zhang X; Zheng G; Yuan J
    Mod Pathol; 2018 May; 31(5):718-731. PubMed ID: 29327711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?
    Eladl E; Chang H
    Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease.
    Varricchio S; Pagliuca F; Travaglino A; Gallo L; Villa MR; Mascolo M
    J Cutan Pathol; 2019 Aug; 46(8):619-622. PubMed ID: 31025408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
    Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
    Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmablastic transformation of plasma cell myeloma with heterotropic expression of CD3 and CD4: a case report.
    Mishra P; Kakri S; Gujral S
    Acta Clin Belg; 2017 Aug; 72(4):250-253. PubMed ID: 27374484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma.
    Gill H; Au-Yeung R; Loong F; Kwong YL
    Ann Hematol; 2022 Jan; 101(1):223-226. PubMed ID: 33760950
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.
    Ahn JS; Okal R; Vos JA; Smolkin M; Kanate AS; Rosado FG
    J Clin Pathol; 2017 Sep; 70(9):775-780. PubMed ID: 28249941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
    Wong YP; Masir N; Chew MX
    Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
    Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
    Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.
    Mori H; Fukatsu M; Ohkawara H; Oka Y; Kataoka Y; Taito S; Ikezoe T
    Int J Hematol; 2021 Dec; 114(6):639-652. PubMed ID: 34462886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvar and gastric involvement in plasmablastic lymphoma.
    Galvão Ferreira PA; Gomes Luna C; Silva MF; Soares LC; Pinho de Oliveira MA
    Eur J Gynaecol Oncol; 2017; 38(2):308-310. PubMed ID: 29953802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmablastic lymphoma with skin involvement in an immunocompetent male.
    Lv B; Yao M; Zhang W; Xiang F
    Asian J Surg; 2023 Dec; 46(12):5677-5678. PubMed ID: 37635027
    [No Abstract]   [Full Text] [Related]  

  • 14. A challenging diagnosis of plasmablastic lymphoma: importance of integrating morpholgy immunohistochemistry and flow cytometry findings (case report).
    Kmira Z; Ahmed G; Wided C; Wided M; Zeineb N; Nihed A; Yosra BY; Regaieg H; Nejia B; Abderrahim K
    Pan Afr Med J; 2023; 45():158. PubMed ID: 37869229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary adrenal plasmablastic lymphoma presenting as lymphomatous meningitis - A diagnostic perplexity.
    Pathak P; Madi DR; Rai P V S; Kassim S; S A
    Cytopathology; 2022 Jan; 33(1):123-126. PubMed ID: 34464483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary testicular plasmablastic lymphoma: unique case in a 30 year old.
    Sachdev R; Goel S
    Indian J Med Res; 2016 Feb; 143(2):251-2. PubMed ID: 27121529
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion.
    Yoshihara K; Yoshihara S; Matsuda I; Imado T; Matsuo S; Okada M; Shimizu Y; Hirota S; Fujimori Y
    Ann Hematol; 2020 Jun; 99(6):1405-1407. PubMed ID: 32125468
    [No Abstract]   [Full Text] [Related]  

  • 18. A rare presentation of plasmablastic lymphoma as cutaneous nodules in an immunocompromised patient.
    Mani SS; Kodiatte T; Jagannati M
    Int J STD AIDS; 2017 May; 28(6):623-625. PubMed ID: 27738277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric plasmablastic lymphoma: Diagnostic and therapeutic dilemma.
    Misra A; Bakhshi S; Kumar R; Chopra A
    Indian J Pathol Microbiol; 2017; 60(2):303-304. PubMed ID: 28631667
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmablastic lymphoma of the testis in an HIV-negative patient: A case report.
    Luo Y; Han L; Zhang W; Zhong J
    Asian J Surg; 2024 Jul; 47(7):3381-3382. PubMed ID: 38604837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.